In fact, the mutant p53 effect may contribute to EGFR expression in MDA-MB-231 cells, as well as in a significant portion of aggressive breast cancers associated with the ‘triple-negative’ profile [22]. The gene discussed is EGFR; the disease is breast carcinoma.